<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Bevacizumab":1,
"Colorectal cancer":3,
"Endoscopy":1,
"Esophageal cancer":1,
"Esophageal metastasis":1,
"FOLFIRI":1,
"FOLFOX":1,
"illness perception":1,
"information":1,
"psychological distress":1,
"survivorship":1,
"thyroid cancer":27,
"Fluorine-18":1,
"Hexafluorophosphate":1,
"PET imaging":1,
"Radiofluorination":1,
"Sodium/iodide symporter":2,
"PET/CT imaging":1,
"computed tomography (CT)":1,
"myocardial perfusion imaging: PET":1,
"Thyroglobulin":3,
"asymmetric distributions":1,
"asymmetric regression models":1,
"heavy-tailed distributions":1,
"left-censoring":1,
"Endobronchial ultrasound":1,
"non-small lung cancer":1,
"positron emission tomography":1,
"staging":1,
"surgery":6,
"MUC21":1,
"epithelioid mesothelioma":1,
"immunohistochemistry":3,
"lung adenocarcinoma":1,
"CHC":1,
"HCC":1,
"dysfonction mitochondriale":1,
"déficit en nutriments":1,
"mitochondrial dysfunction":1,
"nutrient deficiency":1,
"oxidative stress":2,
"shikonin":1,
"shikonine":1,
"stress oxydant":1,
"8th AJCC/TNM staging system":1,
"outcome":3,
"poorly differentiated thyroid cancer":1,
"response to therapy":1,
"survival":4,
"MDM2":1,
"haplotype":1,
"papillary thyroid carcinoma":21,
"polymorphism":1,
"esophageal cancers":1,
"esophagectomy":1,
"lymphadenectomy":1,
"mediastinum":1,
"minimally invasive esophagectomy":1,
"Thyroid surgery":1,
"Transcutaneous laryngeal ultrasound":1,
"Vocal cord mobility":1,
"intraoperative nerve monitoring":1,
"nodal classification":1,
"recurrent laryngeal nerve paralysis":1,
"tumor classification":1,
"Machine learning":1,
"Radionuclide imaging":1,
"Thyroid nodule":12,
"Thyrotropin":1,
"Ultrasonography, Doppler":1,
"Lenvatinib":7,
"Local ablative therapy":2,
"Metastatic thyroid cancer":2,
"Oligoprogression":2,
"Tyrosine kinase inhibitors":2,
"CREB1":1,
"CREBBP":1,
"H3K27Ac":1,
"LINC01857":1,
"breast cancer":10,
"progression":1,
"DNA methylation":1,
"promoter":1,
"telomerase":1,
"RNA-Seq":1,
"rearrangement":1,
"transcript fusion":1,
"MAPK pathway":1,
"Nrf2":1,
"Pinelliae rhizome":1,
"Xiaotan Sanjie decoction":1,
"autophagy":1,
"papillary thyroid cancer":9,
"111In-CP04":1,
"clinical trial":1,
"peptide radiopharmaceuticals":1,
"regulatory framework":1,
"theranostics nuclear medicine":1,
"FOXE1":2,
"Gli2":1,
"hedgehog":1,
"wnt/β-catenin":1,
"Margin":1,
"Meta-analysis":1,
"Recurrence":3,
"Systematic review":1,
"Thyroidectomy":10,
"lateral neck metastasis":1,
"lymph node metastasis":4,
"serum VEGF-C":1,
"aerodigestive tract":1,
"extrathyroidal extension":2,
"papillary carcinoma":2,
"positive margins":1,
"radioactive iodine":2,
"Twist1":1,
"hepatocellular carcinoma (HCC)":1,
"invasion":5,
"migration":2,
"propofol":1,
"biomarker":3,
"miR-4458":1,
"suppressor of cytokine signaling 1":1,
"follicular thyroid carcinoma":4,
"metastasis":7,
"thyroid neoplasm":2,
"ultrasonography":5,
"immune cell":1,
"multiplex immunohistochemistry":1,
"tumor microenvironment":2,
"AGREE":1,
"Evidence-based medicine":1,
"Fine needle aspiration":4,
"Guideline":2,
"Thyroid":11,
"TI-RADS":2,
"TIRADS":1,
"imaging":1,
"reporting systems":1,
"Italy":2,
"incidence":2,
"overdiagnosis":1,
"Age":2,
"Gender":1,
"Metabolic syndrome":1,
"Thyroid nodules":5,
"Thyroid volume":1,
"High-intensity focused ultrasound (HIFU)":1,
"Thermal ablation":1,
"PI3K/Akt pathway":1,
"TRIM26":1,
"tripartite motif family":1,
"tumor suppressor":1,
"LINC01433":1,
"MYC":1,
"miR-2116-3p":1,
"carbon nanoparticles":1,
"endoscopic thyroidectomy":1,
"lymph node dissection":1,
"parathyroid":2,
"recurrent laryngeal nerve":2,
"ITGA3":1,
"miR-524-5p":1,
"microRNA":2,
"PI3K/AKT signaling pathway":1,
"SPP1":1,
"epithelial-mesenchymal transition":2,
"gastric cancer":2,
"microRNA-340":1,
"E-cadherin":1,
"Smad pathway":1,
"TGF-β":2,
"Turmeric, Curcumin":1,
"Vimentin":1,
"miR-183":1,
"phosphatidylinositol 3-kinase/AKT pathway":1,
"prognosis":8,
"transcription factor 12":1,
"atrial fibrillation":1,
"cardiovascular events":1,
"differentiated thyroid carcinoma":3,
"EU-TIRADS":1,
"risk":1,
"ultrasound":3,
"microRNA classifier":2,
"molecular analysis":1,
"mutation":1,
"patient outcomes":1,
"Brazil":1,
"adolescents":1,
"childhood":3,
"population-based registries":1,
"rare tumors":1,
"cancer":8,
"mental health":1,
"psychiatric utilization":1,
"psycho-oncology":1,
"suicidal death":1,
"suicide":1,
"MCM3AP-AS1":1,
"Therapeutic target":1,
"Bethesda System for Reporting Thyroid Cytopathology (BSRTC)":1,
"atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS)":1,
"sonography":1,
"DNA-based screening":1,
"RET proto-oncogene":1,
"biochemical cure":1,
"medullary thyroid carcinoma":7,
"prophylactic thyroidectomy":1,
"model":1,
"preoperative":1,
"HIV and cancer":1,
"National Cancer Data Base":1,
"cancer patient mortality":1,
"cancer stage":1,
"health insurance and mortality":1,
"Cognitive impairment":1,
"TSH suppression therapy":1,
"MALDI mass spectrometry imaging":1,
"NIFTP":1,
"proteomics":1,
"thyroid pathology":1,
"body composition":1,
"metabolic changes":1,
"resting energy expenditure":1,
"subclinical hyperthyroidism":1,
"thyroid carcinoma":6,
"TNBC":1,
"durvalumab":1,
"immunotherapy":4,
"neoadjuvant":2,
"Anaplastic thyroid cancer (ATC)":1,
"Apoptosis":3,
"HLA complex P5 (HCP5)":1,
"Viability":1,
"microRNA-128-3p":1,
"preferences":1,
"surveillance":1,
"well-being":1,
"Overall survival":1,
"Prospective cohort study":1,
"Randomized control trial":1,
"SELECT BC":1,
"Trial effect":1,
"Hyperinsulinemia":1,
"Insulin resistance":2,
"Risk factor":1,
"Thyroid peroxidase antibody":1,
"Gallic acid":1,
"LC-MS":1,
"Metal organic frameworks":1,
"Ribosylated metabolites":1,
"Selectivity":1,
"UiO-66":1,
"estrogen receptor":1,
"nomogram":3,
"Forkhead box E1":1,
"Migration and invasion":1,
"Platelet-derived growth factor":1,
"Proliferation":5,
"Microvessels":1,
"lncRNA AFAP1-AS1":1,
"lncRNA GAS8-AS1":1,
"FBXL19-AS1":1,
"LIN28A":1,
"Tumor progression":1,
"WDR66":1,
"American Thyroid Association":1,
"follicular thyroid cancer":2,
"thyroid neoplasms":6,
"Cell line":2,
"Characteristic":1,
"Dog":1,
"RET gene":1,
"thyroid carcinogenesis":1,
"thyroid stem cells":1,
"thyrospheres":1,
"tungsten":1,
"BRAF":3,
"cancer therapeutics":1,
"p21-activated kinase":1,
"CXCL8":2,
"chemokine receptors":1,
"Jordan":1,
"hyperthyroidism":1,
"hypothyroidism":1,
"prevalence":2,
"thyroid dysfunction":1,
"Circulating tumor cells":1,
"Differentiated thyroid cancer":2,
"Radioactive iodine-131 therapy":1,
"cytology":3,
"digital image analysis":1,
"fine-needle aspiration":2,
"noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP)":1,
"quantitative":1,
"Afirma":1,
"indeterminate thyroid nodules":1,
"molecular diagnostic testing":1,
"PD-1/PD-L1":1,
"cytokines":1,
"monoclonal antibodies":1,
"active surveillance":3,
"papillary thyroid microcarcinoma":1,
"physical health":1,
"psychological health":1,
"quality of life":1,
"VEGFR":1,
"adverse effect":1,
"drug toxicity":1,
"partial response":1,
"sorafenib":2,
"stable disease":1,
"targeted therapy":3,
"Bladder cancer":1,
"STAT3":1,
"Self-renewal":1,
"lnc-DILC":1,
"Hypnotic":1,
"Sedative":1,
"polo-like kinase inhibitor":1,
"volasertib":1,
"well-differentiated thyroid cancer":1,
"Core needle biopsy":1,
"Pain":1,
"TOETVA":1,
"indications":1,
"morbidity":1,
"results":1,
"transoral endoscopic thyroidectomy vestibular approach":1,
"cancer cure":1,
"population-based cancer registries":1,
"dynamic risk assessment":1,
"H3K4me2":1,
"KDM1A":1,
"TIMP1":1,
"lymphatic metastasis":1,
"iodothyronine deiodinase 2":1,
"iopanoic acid":1,
"thyroid hormone":1,
"tumor angiogenesis":1,
"Watson for Oncology":1,
"artificial intelligence":1,
"iodine radioisotopes":1,
"bilateral surgery":1,
"neuromonitoring":1,
"vocal cord paralysis":1,
"death":1,
"survivors":1,
"worry":1,
"Atypia of undetermined significance/follicular lesion of undetermined significance":1,
"Fine needle aspiration cytology":2,
"Nuclear groove":1,
"Nuclear overlapping":1,
"Nuclear scoring":1,
"medullary thyroid cancer":1,
"molecular target therapy":1,
"tyrosine kinase inhibitor":3,
"androgen insensitivity syndromes (AIS)":1,
"androgen receptor":1,
"glucocorticoid receptor":1,
"hormone resistance":1,
"ligand-binding domain":1,
"multimerization":1,
"prostate cancer":1,
"protein structure":1,
"Bethesda criteria":1,
"Thyroid ultrasound":1,
"Gene expression classifier":1,
"Gene mutations":1,
"Gene sequencing":1,
"Indeterminate thyroid nodule":1,
"Molecular testing":1,
"Mutational analysis":1,
"Extent of resection":1,
"Low-risk thyroid cancer":1,
"Thyroid lobectomy":1,
"Lymph nodes":1,
"Lymphadenopathy":1,
"Metastatic disease":1,
"Neck dissection":2,
"Percutaneous ethanol ablation":1,
"Multiple endocrine neoplasia type 1":1,
"Multiple endocrine neoplasia type 2":1,
"Pancreas":1,
"Pheochromocytoma":1,
"Surgical management":1,
"anoikis resistance":1,
"integrin alpha 6":1,
"miRNA-363-3p":1,
"ADPGK-AS1":1,
"OTX1":1,
"miR-3196":1,
"NOTCH1":1,
"benign thyroid nodule":1,
"follicular adenoma":1,
"17-OHP":1,
"17-hydroxyprogesterone":1,
"21- hydroxylase deficiency":1,
"21-OHD":1,
"NC-CAH polycystic ovary syndrome":1,
"PCOS":1,
"non-classic adrenal hyperplasia":1,
"RFA":1,
"autonomous nodule":1,
"cystic nodule":1,
"laser ablation":1,
"thermoablation":1,
"18F-FDG":1,
"Cachexia":1,
"Cardio-oncology":1,
"Glucose metabolism":1,
"Hodgkin's lymphoma":1,
"PET-CT":1,
"Capsaicin":1,
"Mesoporous silica":1,
"Photo-triggered":1,
"5-aza-2′-deoxycytidine":1,
"DNMT3A":1,
"Exome sequencing":1,
"expression":1,
"promoter mutation":1,
"prognostic marker":1,
"Fluorescence Microscopy":1,
"Bethesda system":1,
"indeterminate":1,
"malignancy":1,
"pediatric":1,
"biopsy":1,
"diagnosis":3,
"scintigraphy":1,
"single-photon emission computed tomography":1,
"clinical trials":1,
"endocrine tumors":1,
"mechanism of action":1,
"metformin":1,
"preclinical evidence":1,
"Thyroid imaging reporting and data system":1,
"MACC1":1,
"cell migration":1,
"malignant melanoma":1,
"miR-338-3p":1,
"anaplastic thyroid cancer":1,
"chemotherapy":1,
"dabrafenib":1,
"dedifferentiated":1,
"pembrolizumab":1,
"sarcomatoid":1,
"squamous":1,
"trametinib":1,
"undifferentiated":1,
"Mouse knockout":1,
"p21":1,
"p53":1,
"elastography":1,
"immune scores":1,
"MEN 2A":1,
"children":1,
"syndrome":1,
"DaVinci SP":1,
"Gasless transoral thyroidectomy":1,
"Vestibular approach":1,
"diabetes":1,
"MKL1":1,
"MMP2":1,
"Smad3":1,
"Ethacridine":1,
"apoptotic cell death":1,
"thyroid cancer cells":1,
"adenoma":1,
"bone metastasis":1,
"follicular carcinoma":1,
"misdiagnosis":1,
"thoracic wall":1,
"Alcohol Consumption":1,
"Ear":1,
"Head And Neck Cancer":2,
"Human Papilloma Virus":1,
"Larynx":2,
"Mouth":1,
"Nose":1,
"Pharynx":1,
"Radiation":1,
"Referral":1,
"Risk Factors":1,
"Smoking":1,
"B-RAF-V600E":1,
"CDKN1A":1,
"CDKN2B":1,
"EGR1":1,
"Glucocorticoid":1,
"Oncogene-induced senescence":1,
"DNA repair":1,
"SNPs":1,
"genetic markers":1,
"genetic susceptibility":1,
"CBX3":1,
"bioinformatics analysis":1,
"clinical significance":2,
"hepatocellular carcinoma":1,
"cardiothoracic surgery":1,
"dermatology":1,
"AJCC staging":1,
"capsular invasion":1,
"lymphovascular invasion":1,
"AKT3":1,
"NF-κB":1,
"miRNA":1,
"case report":3,
"antiangiogenic treatment":1,
"embolization":1,
"patient safety":1,
"Diagnostic criteria":1,
"Painful goiter":1,
"Subacute thyroiditis":1,
"Gingiva squamous cell carcinoma":1,
"Marginal mandibulectomy":1,
"Oral squamous cell carcinoma":2,
"Nodular lymphocytic thyroiditis":1,
"Pre-cancerous factors":1,
"Subclinical hypothyroidism":1,
"TSH serum levels":1,
"cardiological comorbidity":1,
"Gene expression regulation":1,
"HDAC inhibitors":1,
"HDACs":1,
"RUNX2":1,
"ear, nose and throat/otolaryngology":1,
"thyroid disease":2,
"advanced thyroid cancer":1,
"radiotherapy":1,
"T reg cells":1,
"angiogenesis":1,
"chemokines":1,
"dendritic cells":1,
"lymphangiogenesis":1,
"macrophages":1,
"mast cells":1,
"neutrophils":1,
"IGF":1,
"IGF inhibitor":1,
"IGF-1R":1,
"acromegaly":1,
"ophthalmopathy":1,
"type 1 IGF receptor":1,
"ECG":1,
"Carcinoma, non-small cell lung":1,
"Carcinoma, squamous cell":1,
"Lung neoplasms":1,
"Neoplasms, multiple primary":1,
"Thyroid cancer, papillary":1,
"131I therapy":1,
"18F-FDG PET/CT":1,
"PTC":1,
"mLN":1,
"C-reactive protein":1,
"Calcitonin":1,
"gingival cyst":1,
"hyperplastic gingivitis":1,
"periodontitis":1,
"peripheral fibroma":1,
"procalcitonin":1,
"saliva":1,
"Keap1 (Kelch-like ECH-associated protein 1)":1,
"Nrf2 (nuclear factor erythroid 2-related factor 2)":1,
"antioxidant":1,
"goiter":1,
"CD15":1,
"cancer stem cell":1,
"thyroid gland":3,
"Cancer Genome Atlas (TCGA)":1,
"gene expression and biological adhesion signature":1,
"thyroid papillary cancer":1,
"Parathyroid adenoma, MIBI scan":1,
"Chyle":1,
"Postoperative complications":1,
"Multifocal":1,
"Neoplasm invasiveness":1,
"Propensity score":1,
"Follicular thyroid adenoma":1,
"Follicular variant papillary thyroid carcinoma":1,
"Gene mutation":1,
"Next-generation sequencing":2,
"Breast neoplasms":1,
"Clinicopathological features":1,
"completion thyroidectomy":1,
"follicular thyroid neoplasm":1,
"guidelines":1,
"treatment recommendations":1,
"carcinogenesis":1,
"cancer immunology":1,
"AKT":1,
"Hürthle cell carcinoma":2,
"cell signaling":1,
"epidermal growth factor receptor":1,
"humans":1,
"near-homozygous genome":1,
"panitumumab":1,
"tumor":2,
"NOTCH":1,
"cancer-driven genes":1,
"germline mutations":1,
"malignant castration-resistant prostatic cells":1,
"mutational mechanism":1,
"neuroendocrine neoplasms":1,
"pancreatic NET":1,
"small bowel NET":1,
"small cell lung carcinoma":1,
"lobectomy":1,
"low-risk thyroid carcinoma":1,
"thyrotropin suppression treatment":1,
"microcarcinoma":1,
"recurrent carcinoma":1,
"disease characteristics":1,
"acoustic voice analysis":1,
"recurrent laryngealnerve":1,
"SWE":1,
"Cyclin D1":1,
"colorectal":1,
"Autotaxin":1,
"Lysophosphatidate":1,
"RAS":1,
"TERT":1,
"Aggressive carcinoma":1,
"Graves’ disease":1,
"Matched cohort":1,
"Outcomes":1,
"drugs and medicines":1,
"endocrinology":1,
"immunology":1,
"thyroiditis":1,
"DOTATATE":1,
"MIBG":1,
"PET/CT":1,
"Peptide receptor radionuclide therapy (PRRT)":1,
"Somatostatin receptor":1,
"Theranostic":1,
"Clinical characteristics":1,
"Delphian lymph node":1,
"Papillary thyroid cancer (PTC)":1,
"biomarkers":1,
"fine needle aspirates (FNAs)":1,
"preoperative diagnostics":1,
"fine needle aspiration (FNA)":2,
"follicular variant":1,
"non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"papillary thyroid carcinoma (PTC)":3,
"frozen sections (FS)":1,
"CASTLE":1,
"PD-L1":2,
"carcinoma":1,
"checkpoint inhibitor":1,
"extrathyroidal":1,
"parotid":1,
"thymus-like":1,
"Cervical lymphectomy":1,
"Lymph node metastases":1,
"One-step nucleic acid amplification (OSNA)":1,
"Real-time PCR":1,
"autofluorescence":1,
"indocyanine green":1,
"near-infrared":1,
"parathyroid gland":1,
"Nuclear power workers":1,
"AKT pathway":1,
"﻿miRNA-15a":1,
"Wnt5a":1,
"microRNA-26a-5p":1,
"neutrophil-to-lymphocyte ratio":1,
"survival analysis":1,
"young patient":1,
"Hashimoto’s thyroiditis (HT)":1,
"anti-thyroid peroxidase antibody (TPOAb)":1,
"Intracranial mature teratoma":1,
"Malignant transformation":1,
"SEER":1,
"ultrasonography (US)":1,
"Sentinel lymph node biopsy (SLNB)":1,
"carbon nanoparticles (CNs)":1,
"second surgery":1,
"carcinosarcoma":1,
"cat":1,
"Ewing sarcoma":1,
"laryngeal cancer":2,
"metastases":1,
"pnets":1,
"ERK":1,
"epithelial-to-mesenchymal transition":1,
"tumor necrosis factor α-induced protein 8-like-1 (TIPE1)":1,
"Deep convolutional neural network":1,
"cytological images":1,
"liquid-based cytology":1,
"Thyroid malignancy":1,
"hyroid nodule Thyroid isotope scan":1,
"HIF1α":1,
"hypoxia":1,
"immune checkpoint antibody":1,
"skin toxicities":1,
"autoimmune encephalitis":1,
"fluorodeoxy glucose positron emission tomography (fdg-pet)":1,
"nmda encephalitis":1,
"seizures":1,
"hematologic tests":1,
"immune system":1,
"lymphocytes":1,
"CITED1":1,
"Wnt/β-catenin signaling":1,
"PDCD4":1,
"BRMS1":1,
"CX43":1,
"anaplastic thyroid carcinoma":1,
"MicroRNA-182":1,
"prognostic value":1,
"NTRK fusions":1,
"ancillary testing":1,
"hepatotoxicity":1,
"metastatic renal cell carcinoma":1,
"nivolumab":1,
"pazopanib":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
